XAVIS Co., Ltd.

XAVIS Co., Ltd.

KKRX:254120
3,700.00
KRW
-35.00
(-0.94%)
-756.27EPS
24.63BMarket Cap
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
2,603.55
6,189.77
2,872.29
3,447.68
4,551.5
5,233.35
6,134.11
4,535.72
4,447.33
Basic EPS, GAAP
-3.24
9.99
-120.33
-2,627.44
-1,549.63
-1,077.81
74.01
-710
215
-645
-730.49
Free Cash Flow per Basic Share
-5.99
13.11
-298.23
-872.89
-727.73
-1,037.96
-562.02
-1,778.29
1,675.35
-254.5
-244.92
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1,727.56
1,737.55
323.23
3,734.52
2,345.16
1,998.7
2,078.14
4,461.7
4,686.14
4,054.52
3,880.51
Tangible Book Value per Share
1,727.56
1,737.55
-153.6
2,821.45
1,646.82
1,854.91
1,977.4
4,398.62
4,576.02
3,960.49
3,797.74
Basic Weighted Avg Shares
2
5
5
3
4
5
5
5
6
6
6
Sales/Revenue/Turnover
- -
- -
12,664
17,060
12,275
16,074
22,323
28,708
37,612
27,895
27,357
Operating Margin (%)
- -
- -
-4.14
-3.39
-15.31
-24.8
-0.06
2.93
3.21
-14.05
-18.41
Depreciation Expense
- -
- -
689
895
1,109
1,572
1,053
1,077
1,078
1,019
1,008
Net Income, GAAP
-6
49
-585
-7,242
-6,623
-5,025
363
-3,895
1,318
-3,967
-4,493
Effective Tax Rate (%)
- -
6.82
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-4.62
-42.45
-53.95
-31.26
1.63
-13.57
3.5
-14.22
-16.43
Working Capital
9,630
- -
2,116
10,295
2,135
3,780
-2,322
21,536
16,128
10,442
14,815
LT Debt
1,207
1,240
4,248
4,455
7,230
7,055
71
7,188
223
640
5,588
Total Equity
8,403
8,452
1,572
15,293
10,576
9,750
10,103
27,498
28,758
24,730
23,590
Return on Invested Capital (%)
- -
-0.54
- -
- -
- -
- -
-0.07
- -
3.71
- -
- -
Return on Capital (%)
- -
0.83
- -
- -
- -
- -
5.76
- -
5.02
- -
- -
Return on Common Equity (%)
- -
0.58
-11.68
-87.25
-52.35
-50.66
3.72
-20.85
4.69
-14.78
-17.25

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1,161
1,908
1,291
LT Borrowings
490
458
5,427
LT Finance Leases
150
109
161
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
6
Market Capitalization
45,792
36,363
24,631

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
22,544
22,822
26,623
Cash, Cash Equivalents & STI
5,115
1,811
7,290
Accounts Receivable, Net
5,193
6,032
4,382
Inventories
11,326
13,361
13,447
Total Current Liabilities
12,102
12,277
11,808
Payables & Accruals
- -
- -
- -
ST Debt
1,161
1,908
1,291
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
31.71%
-14%
Free Cash Flow
- -
-10.82%
-115.24%
Net Income, GAAP
- -
-367.81%
-400.9%
Sales/Revenue/Turnover
- -
20.72%
-25.83%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
11,335
12,084
5,773
8,421
37,612
2025
4,880
9,008
7,010
6,998
27,895
2026
5,274
8,076
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
75
190
-105
58.18
215
2025
-70
-20
-38.44
-517.15
-645
2026
-95.48
-80
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Hyeong-Cheol Kim
Full Time Employees
160
Sector
Health technology
Industry
Medical specialties
Address
Seongnam-si South Korea
IPO Date
Dec 2, 2016
Business
XAVIS Co., Ltd. is a South Korea-based technology company primarily engaged in the research, design, and manufacturing of non-destructive X-ray inspection systems and automated machine vision solutions. Founded in 2002 and headquartered in Seongnam-si, Gyeonggi-do, South Korea, the company develops specialized inspection equipment across two primary business divisions: industrial inspection systems (Xscan) and food and pharmaceutical inspection systems (Fscan). Its industrial product portfolio includes automated X-ray inspection (AXI) systems and computed tomography (CT) equipment for secondary battery manufacturing across pouch, prismatic, and cylindrical form factors; semiconductor and microelectronics inspection platforms for high-bandwidth memory (HBM), flip-chip packages, and wafer-level packaging; automated inline and offline surface mount technology (SMT) and printed circuit board (PCB) inspection systems; and heavy-duty inspection machinery for automotive parts and metal die-casting quality assurance. Its food and pharmaceutical offerings consist of inline X-ray inspection systems designed to detect foreign contaminants such as metals, glass, stone, bone fragments, and high-density plastics, alongside automated quality control functions for defect detection, missing component verification, fill-level monitoring, and package seal inspection. The company also supplies proprietary image processing software, technical support, and equipment maintenance services. XAVIS distributes its products domestically and internationally across North America, Europe, and Asia, operating through international subsidiaries and partner networks in markets including China, Vietnam, and Japan. In recent developments, XAVIS has formally amended its corporate objectives to incorporate artificial intelligence software and hardware platforms, integrating deep learning algorithms into its core vision and inspection software to enhance defect identification accuracy and speed. The company has expanded its secondary battery solutions with proprietary rotary optics-based CT inspection systems engineered for energy storage systems (ESS) and next-generation 4680 cylindrical batteries, while launching advanced 2.5D laminography inspection platforms such as the Xscan-9800T25. Additionally, XAVIS has entered the advanced semiconductor packaging sector by developing inspection equipment for Through Glass Via (TGV) and Co-Packaged Optics (CPO) glass substrates utilized in artificial intelligence computing architectures, contributing to significant growth in its industrial inspection order backlog.